liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer
Sichuan Univ, Peoples R China.
Sichuan Univ, Peoples R China.
Sichuan Univ, Peoples R China.
Linköping University, Department of Clinical and Experimental Medicine, Division of Surgery, Orthopedics and Oncology. Linköping University, Faculty of Medicine and Health Sciences. Sichuan Univ, Peoples R China; Sichuan Univ, Peoples R China.
Show others and affiliations
2019 (English)In: Future Oncology, ISSN 1479-6694, E-ISSN 1744-8301, Vol. 15, no 18, p. 2093-2106Article in journal (Refereed) Published
Abstract [en]

Aim: To investigate the association and prognostic value of ANKZF1 gene for survival in colorectal cancer, the mechanism of ANKZF1 level alteration and correlated signaling pathways ANKZF1 is involved. Patients amp; methods: The Cancer Genome Atlas COREAD dataset was analyzed by bioinformatical investigation. Results: High ANKZF1 expression is associated with poor overall survival (hazard ratio [HR]: 2.094; 95% CI: 1.188-3.689; p=0.011) and recurrence-free survival (HR: 1.762; 95% CI: 1.021-3.042; p=0.042) in colon cancer. Bioinformatical analysis showed ANKZF1 was upregulated by amplification and exon expression. ANKZF1 was associated with angiogenesis and cancer signaling pathways. Conclusion: High ANKZF1 is an independent factor of poor survival (overall survival and recurrence-free survival) in colon cancer by taking part in angiogenesis and some cancer signaling pathways.

Place, publisher, year, edition, pages
FUTURE MEDICINE LTD , 2019. Vol. 15, no 18, p. 2093-2106
Keywords [en]
ANKZF1; colon cancer; OS; overall survival; recurrence-free survival; RFS; WGCNA
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-160630DOI: 10.2217/fon-2018-0920ISI: 000485097700004PubMedID: 31257922OAI: oai:DiVA.org:liu-160630DiVA, id: diva2:1360198
Note

Funding Agencies|Natural Science Foundation of ChinaNational Natural Science Foundation of China [81402446]; Research Foundation of Health and Family Planning Commission of Sichuan Province [150136]

Available from: 2019-10-11 Created: 2019-10-11 Last updated: 2019-10-11

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Fan, Chuanwen
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health Sciences
In the same journal
Future Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 43 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf